{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:04:03Z","timestamp":1791237843418,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006701","name":"Umm Al-Qura University","doi-asserted-by":"publisher","award":["26UQU4290365GSSR01"],"award-info":[{"award-number":["26UQU4290365GSSR01"]}],"id":[{"id":"10.13039\/501100006701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.intimp.2026.116692","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T04:57:19Z","timestamp":1777179439000},"page":"116692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["STING-Activating Nanomedicines in Cancer Immunotherapy: Mechanisms, Design, and Therapeutic Outcomes"],"prefix":"10.1016","volume":"180","author":[{"given":"Harshita","family":"Singhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urushi","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena Mohammed","family":"Bukhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Kumar","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116692_bb0005","doi-asserted-by":"crossref","unstructured":"Z. Liu, N. Parveen, U. Rehman, A. Aziz, A. Sheikh, M.A.S. Abourehab, W. Guo, J. Huang, Z. Wang, P. Kesharwani, Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer, Mol. Cancer 221 22 (2023) 1\u201322. doi:10.1186\/S12943-022-01696-5.","DOI":"10.1186\/s12943-022-01696-5"},{"key":"10.1016\/j.intimp.2026.116692_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.intimp.2026.116692_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2016.06.029","article-title":"RNAi-combined nano-chemotherapeutics to tackle resistant tumors","author":"Tekade","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2026.116692_bb0020","series-title":"Nanotechnology-based targeted drug delivery systems for brain tumors","author":"Kesharwani","year":"2018"},{"key":"10.1016\/j.intimp.2026.116692_bb0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jconrel.2021.08.003","article-title":"Advanced nanomedicine approaches applied for treatment of skin carcinoma","volume":"337","author":"Kaur","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116692_bb0030","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/acs.molpharmaceut.5b00827","article-title":"In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas","volume":"12","author":"Amjad","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2026.116692_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.111898","article-title":"Emerging application of magnetic nanoparticles for breast cancer therapy","volume":"187","author":"Dongsar","year":"2023","journal-title":"Eur. Polym. J."},{"issue":"15","key":"10.1016\/j.intimp.2026.116692_bb0040","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2217\/nnm.13.210","article-title":"Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector","volume":"9","author":"Kesharwani","year":"2014","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.intimp.2026.116692_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcis.2016.07.047","article-title":"Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment","volume":"482","author":"Patel","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.intimp.2026.116692_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/imm.13918","article-title":"Ammonia-Induced Cell Death: A Novel Frontier to Enhance Cancer Immunotherapy","volume":"175","author":"Rehman","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2026.116692_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drudis.2019.11.003","article-title":"Immune checkpoint inhibitors: a promising anticancer therapy","volume":"25","author":"Singh","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2026.116692_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2021.03.011","article-title":"The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer","author":"Singh","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2026.116692_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111471","article-title":"Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy","volume":"177","author":"Mukherjee","year":"2022","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.intimp.2026.116692_bb0070","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2022.05.046","article-title":"Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases","volume":"348","author":"Rahiman","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116692_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0819-1","article-title":"CAR-T \u201cthe living drugs\u201d, immune checkpoint inhibitors, and precision medicine: A new era of cancer therapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.116692_bb0080","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2020","journal-title":"Med"},{"key":"10.1016\/j.intimp.2026.116692_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01476-9","article-title":"Nanoparticles mediated tumor microenvironment modulation: current advances and applications","volume":"20","author":"Raju","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2026.116692_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106417","article-title":"Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care","volume":"83","author":"Singh","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116692_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111781","article-title":"Immunoliposomes as an emerging nanocarrier for breast cancer therapy","volume":"184","author":"Parveen","year":"2023","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.intimp.2026.116692_bb0100","series-title":"Role of exosomes in tumour growth, chemoresistance and immunity: state-of-the-art","author":"Hosseinikhah","year":"2022"},{"key":"10.1016\/j.intimp.2026.116692_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116823","article-title":"A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response","volume":"236","author":"Jha","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.intimp.2026.116692_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109300","article-title":"Immune checkpoint blockade in melanoma: Advantages, shortcomings and emerging roles of the nanoparticles","volume":"113","author":"Mahdavi Gorabi","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116692_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.792","article-title":"LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS\/STING signalling in non-small cell lung cancer","volume":"12","author":"Gao","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116692_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166031","article-title":"Glycolysis drives STING signaling to facilitate dendritic cell antitumor function","volume":"133","author":"Hu","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.116692_bb0125","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.immuni.2013.05.004","article-title":"Immune Sensing of DNA","volume":"38","author":"Paludan","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116692_bb0130","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: Infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116692_bb0135","first-page":"1","article-title":"Activation of STING requires palmitoylation at the Golgi","volume":"71","author":"Mukai","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116692_bb0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116692_bb0145","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/toxins6061696","article-title":"Type I interferons as regulators of human antigen presenting cell functions","volume":"6","author":"Gessani","year":"2014","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.intimp.2026.116692_bb0150","article-title":"cGAS\u2013STING, an important signaling pathway in diseases and their therapy","volume":"5","author":"Li","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2026.116692_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2026.108991","article-title":"Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistance","volume":"280","author":"Wang","year":"2026","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2026.116692_bb0160","article-title":"The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116692_bb0165","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1038\/s41598-021-86490-x","article-title":"Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction","volume":"111","author":"Ditano","year":"2021","journal-title":"Sci. Report."},{"key":"10.1016\/j.intimp.2026.116692_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"Smith","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116692_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156980","article-title":"ATM and ATR inhibition increases radiosensitivity and cGAS-STING activation in prostate cancer","volume":"193","author":"van Campen","year":"2025","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2026.116692_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado4618","article-title":"ATR inhibition activates cancer cell cGAS\/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer","volume":"10","author":"Taniguchi","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2026.116692_bb0185","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-cancerbio-030518-055636","article-title":"Roles of the cGAS-STING pathway in cancer immunosurveillance and immunotherapy","volume":"3","author":"Yum","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.116692_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9013","article-title":"cGAS-STING-mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy","volume":"12","author":"Li","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116692_bb0195","first-page":"1","article-title":"Challenges and opportunities in the clinical development of sting agonists for cancer immunotherapy","volume":"9","author":"Aval","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.116692_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imr.12765","article-title":"STING pathway agonism as a cancer therapeutic","volume":"290","author":"Flood","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2026.116692_bb0205","unstructured":"Macromolecular Bioscience - 2021 - Zhou - Nanoparticle-Mediated STING Agonist Delivery for Enhanced Cancer Immunotherapy.pdf, (n.d.)."},{"key":"10.1016\/j.intimp.2026.116692_bb0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molmed.2019.02.007","article-title":"Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy","volume":"25","author":"Berger","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2026.116692_bb0215","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.intimp.2026.116692_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-023-00551-z","article-title":"Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.intimp.2026.116692_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18626-y","article-title":"Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis","volume":"11","author":"Rao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116692_bb0230","doi-asserted-by":"crossref","unstructured":"A. Decout, J.D. Katz, S. Venkatraman, A. Ablasser, The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases, Nat. Rev. Immunol.. 219 21 (2021) 548\u2013569. doi:https:\/\/doi.org\/10.1038\/s41577-021-00524-z.","DOI":"10.1038\/s41577-021-00524-z"},{"issue":"21","key":"10.1016\/j.intimp.2026.116692_bb0235","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS\u2013STING signalling","volume":"219","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116692_bb0240","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116692_bb0245","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.micinf.2014.10.002","article-title":"The STING controlled cytosolic-DNA activated innate immune pathway and microbial disease","volume":"16","author":"Konno","year":"2014","journal-title":"Microbes Infect."},{"key":"10.1016\/j.intimp.2026.116692_bb0250","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type i interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116692_bb0255","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116692_bb0260","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","article-title":"Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response","volume":"49","author":"Marcus","year":"2018","journal-title":"Immunity"},{"issue":"553","key":"10.1016\/j.intimp.2026.116692_bb0265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"5537689","author":"Bakhoum","year":"2018","journal-title":"Nat"},{"key":"10.1016\/j.intimp.2026.116692_bb0270","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","article-title":"Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response","volume":"49","author":"Marcus","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116692_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217410","article-title":"STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development","volume":"612","author":"Zhang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.116692_bb0280","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-025-04206-w","article-title":"cGAS-STING and autophagy: crosstalk, molecular mechanisms, and targeted therapy","volume":"100","author":"Wang","year":"2026","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.intimp.2026.116692_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116203","article-title":"Crosstalk between cGAS-STING and pyroptosis: From molecular mechanisms to therapeutic strategies","volume":"172","author":"Wang","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116692_bb0290","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1007\/s00204-025-04150-9","article-title":"Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects","volume":"99","author":"Wang","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.intimp.2026.116692_bb0295","doi-asserted-by":"crossref","first-page":"1399926","DOI":"10.3389\/fimmu.2024.1399926","article-title":"Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116692_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216409","article-title":"cGAS-STING signaling in the tumor microenvironment","volume":"577","author":"Liu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.116692_bb0305","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12964-024-01860-y","article-title":"cGAS\/STING in skin melanoma: from molecular mechanisms to therapeutics","volume":"22","author":"Mahin","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2026.116692_bb0310","article-title":"Discovery of a non-nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect","volume":"6","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2026.116692_bb0315","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.3390\/molecules29133121","article-title":"Agonists and Inhibitors of the cGAS-STING Pathway","volume":"29","author":"Yu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116692_bb0320","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-020-2719-5","article-title":"STING cyclic dinucleotide sensing originated in bacteria","volume":"586","author":"Morehouse","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116692_bb0325","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jare.2022.05.006","article-title":"STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape","volume":"44","author":"Kong","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2026.116692_bb0330","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.celrep.2017.11.061","article-title":"Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and Can Be Targeted to Enhance Anti-tumor Response","volume":"21","author":"Gonugunta","year":"2017","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.intimp.2026.116692_bb0335","article-title":"The Many Ways to Deal with STING","volume":"24","author":"Coderch","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116692_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112869","article-title":"The discovery of potent small molecule activators of human STING","volume":"209","author":"Pryde","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2026.116692_bb0345","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1038\/s41598-022-12449-1","article-title":"SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis","volume":"121","author":"Song","year":"2022","journal-title":"Sci. Report."},{"key":"10.1016\/j.intimp.2026.116692_bb0350","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","article-title":"Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116692_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.567348","article-title":"Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses","volume":"11","author":"Kennedy","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116692_bb0360","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1039\/D4BM01532K","article-title":"Enhancing nano-immunotherapy of cancer through cGAS\u2013STING pathway modulation","volume":"13","author":"Fu","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.intimp.2026.116692_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103105","article-title":"Delivery of STING agonists for cancer immunotherapy","volume":"87","author":"Wang","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.intimp.2026.116692_bb0370","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.7150\/thno.38069","article-title":"Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics","volume":"10","author":"Mi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2026.116692_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp9071","article-title":"An \u201cAND\u201d logic gate\u2013based supramolecular therapeutic nanoplatform for combatting drug-resistant non\u2013small cell lung cancer","volume":"10","author":"Huang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2026.116692_bb0380","doi-asserted-by":"crossref","first-page":"16488","DOI":"10.1039\/D3RA00866E","article-title":"Stimuli-responsive nanocarrier delivery systems for Pt-based antitumor complexes: a review","volume":"13","author":"Wang","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.intimp.2026.116692_bb0385","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.2147\/IJN.S455213","article-title":"Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment","volume":"19","author":"Lang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"16","key":"10.1016\/j.intimp.2026.116692_bb0390","article-title":"Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung","volume":"161","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116692_bb0395","doi-asserted-by":"crossref","first-page":"1485546","DOI":"10.3389\/fimmu.2024.1485546","article-title":"Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116692_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38900","article-title":"Recent advances in nanoadjuvant-triggered STING activation for enhanced cancer immunotherapy","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2026.116692_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01566-5","article-title":"Host STING-dependent MDSC mobilization drives extrinsic radiation resistance","volume":"8","author":"Liang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116692_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113789","article-title":"Hypoxia-responsive albumin nanoparticles co-delivering banoxantrone and STING agonist enhance immunotherapy of high-intensity focused ultrasound","volume":"383","author":"Huang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116692_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101797","article-title":"Article A dual-STING-activating nanosystem expands cancer immunotherapeutic temporal window ll ll A dual-STING-activating nanosystem expands cancer immunotherapeutic temporal window","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.intimp.2026.116692_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.061","article-title":"STING pathway activation with cisplatin polyprodrug nanoparticles for chemo-immunotherapy in ovarian cancer","volume":"381","author":"Fu","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116692_bb0425","article-title":"Materials Today Bio Mn-phenolic networks as synergistic carrier for STING agonists in tumor immunotherapy","volume":"26","author":"Meng","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.intimp.2026.116692_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102749","article-title":"A nuclei bombing nano-system improves STING-activated cancer immunotherapy","volume":"63","author":"Guo","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.intimp.2026.116692_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.109856","article-title":"Tumor-responsive covalent organic polymeric nanoparticles enhancing STING activation for cancer immunotherapy","volume":"36","author":"Liang","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.intimp.2026.116692_bb0440","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3390\/molecules29153704","article-title":"Recent Progress in Photothermal, Photodynamic and Sonodynamic Cancer Therapy: Through the cGAS-STING Pathway to Efficacy-Enhancing Strategies","volume":"29","author":"Fang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116692_bb0445","doi-asserted-by":"crossref","first-page":"2204365","DOI":"10.1002\/advs.202204365","article-title":"Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy","volume":"10","author":"Yang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.intimp.2026.116692_bb0450","series-title":"Logic-gated approach for targeted delivery and site-selective activation of photothermal agents in precision cancer treatment \u2020","author":"Jiang","year":"2025"},{"key":"10.1016\/j.intimp.2026.116692_bb0455","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/sciadv.adr1728","article-title":"Tumor-targeting nanocarriers amplified immunotherapy of cold tumors by STING activation and inhibiting immune evasion","volume":"11","author":"Zhao","year":"2025","journal-title":"Sci. Adv."},{"issue":"14","key":"10.1016\/j.intimp.2026.116692_bb0460","article-title":"Cholesterol removal improves performance of a model biomimetic system to co-deliver a photothermal agent and a STING agonist for cancer immunotherapy","volume":"141","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116692_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122905","article-title":"Biologically logic-gated Trojan-horse strategy for personalized triple-negative breast cancer precise therapy by selective ferroptosis and STING pathway provoking","volume":"315","author":"Guo","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116692_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123434","article-title":"Amplification of cGAS-STING pathway with \u201csingle-molecule multitarget\u201d nanoparticles for chemo-immunotherapy of ovarian cancer","volume":"323","author":"Fu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116692_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102727","article-title":"J-Aggregated indocyanine green-loaded exosomes enable photoactivatable cytoplasmic delivery of STING agonist for targeted pancreatic cancer immunotherapy","volume":"62","author":"Li","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.intimp.2026.116692_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123126","article-title":"Photochemical bomb: Precision nuclear targeting to activate cGAS-STING pathway for enhanced bladder cancer immunotherapy","volume":"318","author":"Feng","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116692_bb0485","first-page":"345","article-title":"Bioactive Materials STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy","volume":"42","author":"Thi","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.intimp.2026.116692_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114467","article-title":"Metal complex lipid-based nanoparticles deliver metabolism-regulating lomitapide to overcome CTC immune evasion via activating STING pathway","volume":"203","author":"Fan","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.intimp.2026.116692_bb0495","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1021\/acsomega.4c10865","article-title":"Unleashing the Potential of Metal Ions in cGAS-STING Activation: Advancing Nanomaterial-Based Tumor Immunotherapy","volume":"10","author":"Li","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.intimp.2026.116692_bb0500","doi-asserted-by":"crossref","first-page":"1416382","DOI":"10.3389\/fphar.2024.1416382","article-title":"Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution","volume":"15","author":"Adzavon","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116692_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113942","article-title":"A cGAS-STING pathway activating cobalt(III) cyclam prodrug for combined chemotherapy and immunotherapy of breast cancer","volume":"384","author":"Song","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116692_bb0510","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jcis.2024.11.224","article-title":"Manganese nanosheets loaded with selenium and gemcitabine activate the tumor microenvironment to enhance anti-tumor immunity","volume":"682","author":"Zhang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.intimp.2026.116692_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102672","article-title":"cGAS-STING-activating nanoreactors with tumor-localized thrombosis- and lipid peroxidation-inducing capacity for combination cancer enzymes and immunotherapy","volume":"61","author":"Wang","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.intimp.2026.116692_bb0520","article-title":"Nanodelivery of arsenic trioxide induces macrophage-governed cGAS-STING signaling to remodel immune microenvironment in hepatocellular carcinoma","volume":"506","author":"Li","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.intimp.2026.116692_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123199","article-title":"Manganese-coordinated nanoparticles loaded with CHK1 inhibitor dually activate cGAS-STING pathway and enhance efficacy of immune checkpoint therapy","volume":"319","author":"Huang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116692_bb0530","article-title":"MXene-based mild photothermal therapy synergizes STING activation to enhance the efficacy of cancer vaccines post-cryoablation","volume":"505","author":"Wang","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.intimp.2026.116692_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123294","article-title":"STING-activating layered double hydroxide nano-adjuvants for enhanced cancer immunotherapy","volume":"321","author":"Jia","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116692_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113407","article-title":"Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus","volume":"12","author":"Froechlich","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.116692_bb0545","doi-asserted-by":"crossref","first-page":"19541","DOI":"10.1038\/s41598-023-46830-5","article-title":"The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties","volume":"13","author":"Froechlich","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116692_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006829","article-title":"The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires\u2019 disease in humans","volume":"14","author":"Ruiz-Moreno","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2026.116692_bb0555","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/1878-0261.13603","article-title":"STING activator 2\u20193\u2019-cGAMP enhanced HSV-1-based oncolytic viral therapy","volume":"18","author":"Sibal","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2026.116692_bb0560","series-title":"Oncolytic HSV: Underpinnings of Tumor Susceptibility, Viruses 2021","first-page":"13","volume":"13","author":"Kangas","year":"2021"},{"key":"10.1016\/j.intimp.2026.116692_bb0565","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1591875","article-title":"Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma","volume":"8","author":"Bommareddy","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2026.116692_bb0570","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/IJN.S515893","article-title":"Nanoparticle-Based Strategies to Enhance the Efficacy of STING Activators in Cancer Immunotherapy","volume":"20","author":"Qiao","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2026.116692_bb0575","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/vaccines9080917","article-title":"The promise and challenges of cyclic dinucleotides as molecular adjuvants for vaccine development","volume":"9","author":"Yan","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2026.116692_bb0580","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.12688\/f1000research.125163.1","article-title":"James, cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma","volume":"11","author":"Heimberger","year":"2022","journal-title":"F1000Research"},{"key":"10.1016\/j.intimp.2026.116692_bb0585","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02366-y","article-title":"Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy","volume":"24","author":"Zeng","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.116692_bb0590","doi-asserted-by":"crossref","first-page":"2500296","DOI":"10.1002\/advs.202500296","article-title":"STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy","volume":"12","author":"Gehrcken","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.intimp.2026.116692_bb0595","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"issue":"24","key":"10.1016\/j.intimp.2026.116692_bb0600","article-title":"Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116692_bb0605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2022.09.007","article-title":"Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models","volume":"351","author":"Jeon","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.116692_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122645","article-title":"Spatiotemporal release of non-nucleotide STING agonist and AKT inhibitor from implantable 3D-printed scaffold for amplified cancer immunotherapy","volume":"311","author":"Wang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116692_bb0615","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.apsb.2025.02.022","article-title":"Bioactive metallic nanoparticles for synergistic cancer immunotherapy","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.intimp.2026.116692_bb0620","article-title":"Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress","volume":"121","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116692_bb0625","article-title":"For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy","volume":"31","author":"Karimi","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.intimp.2026.116692_bb0630","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10238-025-01838-1","article-title":"Unlocking the therapeutic potential of the STING signaling pathway in anti-tumor treatment","volume":"25","author":"Li","year":"2025","journal-title":"Clin. Exp. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:23:00Z","timestamp":1783052580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926005382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":126,"alternative-id":["S1567576926005382"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116692","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STING-Activating Nanomedicines in Cancer Immunotherapy: Mechanisms, Design, and Therapeutic Outcomes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116692"}}